Astrana Health Valuation

Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Astrana Health prevailing Real Value cannot be determined due to lack of data. The current price of Astrana Health is $0.0. Our model approximates the value of Astrana Health from analyzing the firm fundamentals such as Current Valuation of 1.81 B, profit margin of 0.03 %, and Return On Equity of 0.0976 as well as examining its technical indicators and probability of bankruptcy.

Astrana Health Total Value Analysis

Astrana Health is presently forecasted to have valuation of 1.81 B with market capitalization of 1.86 B, debt of 229.36 M, and cash on hands of 273.71 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Astrana Health fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
1.81 B
1.86 B
229.36 M
273.71 M

Astrana Health Investor Information

About 26.0% of the company shares are held by company insiders. The book value of Astrana Health was presently reported as 12.74. The company had not issued any dividends in recent years. Astrana Health had 1:10 split on the 27th of April 2015. Astrana Health is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.

Astrana Health Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Astrana Health has an asset utilization ratio of 137.43 percent. This signifies that the Company is making $1.37 for each dollar of assets. An increasing asset utilization means that Astrana Health is more efficient with each dollar of assets it utilizes for everyday operations.

Astrana Health Ownership Allocation

Astrana Health holds a total of 45.45 Million outstanding shares. Astrana Health retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Astrana Health Profitability Analysis

The company reported the previous year's revenue of 1.33 B. Net Income was 48.51 M with profit before overhead, payroll, taxes, and interest of 199.48 M.

Astrana Health Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding45.6 M
Quarterly Earnings Growth Y O Y-0.06
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Consideration for investing in Astrana Stock

If you are still planning to invest in Astrana Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Astrana Health's history and understand the potential risks before investing.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine